BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 23, 2001
View Archived Issues
Human Genome Sciences makes significant progress in several areas during 2000
Read More
Karo Bio provides company update
Read More
Alliance to develop allergy treatments established by Maxygen and ALK-Abello
Read More
FDA requests further information for Campath BLA
Read More
Vita-Invest's combination therapy for hypertension completes phase III
Read More
GlaxoSmithKline and Sepsicure establish agreement for sepsis treatment
Read More
Novel asthma gene identified as part of joint scientific collaboration
Read More
Telik's TLK-286 completes phase I evaluation
Read More
FDA accepts AHP's PMA for unique bone growth protein
Read More
Phase I/II program for NBI-6024 expanded; pivotal phase IIb trial to commence later this year
Read More
Adipose tissue hormone reduces body weight by increasing FFA oxidation
Read More
Avant reports preliminary results of phase I extension trial for cholesterol management vaccine
Read More
Patient enrollment complete in phase III trial of beraprost for intermittent claudication
Read More
Adenoviral gene transfer of eNOS for improving age-related erectile dysfunction
Read More
Rifabutin-based triple regimen as rescue therapy for resistant H. pylori infection
Read More
Vion cleared to proceed with clinical trial of anticancer agent VNP-40101M
Read More
Esomeprazole effective for maintaining healing of erosive esophagitis; receives major approval
Read More
CuraGen and Bayer cleared to proceed with landmark genomic agreements
Read More
Japanese introduction announced for new atypical antipsychotic
Read More
Securiosides selectively cytotoxic to M-CSF-stimulated macrophages
Read More
Resveratrol reported to have selective antibacterial activity against Neisseria
Read More
HIV vaccines comprising adenoviral vector and gag genes described by Merck
Read More
Texas university researchers identify PEA3 as a tumor suppressor for cancer treatment
Read More
Potent antibacterial group A streptogramin derivatives designed at Aventis
Read More
Fujisawa discloses inhibitors of NO production
Read More
Selective ETA receptor ligands and their use reported by Pfizer scientists
Read More
Novel antipruritic agents in development at Pfizer
Read More